Geneva’s FIF grants $122,000 to AI epilepsy tool dEEGtal
What's the deal? dEEGtalDealroom has a profile for this one. Try Dealroom →, a Geneva-based startup building AI software for EEG analysis, has received a US$91.7K FIF Seed Tech grant. The award is one of four handed out by the FIF, the Canton of Geneva’s innovation financing programme, which backs technology-driven startups, scaleups, and SMEs.
What's the endgame? Based at the Wyss Center for Bio and Neuroengineering at Campus Biotech, dEEGtal uses artificial intelligence to support more precise epilepsy diagnosis. Developed from research at Geneva University Hospitals, its software helps neurologists uncover diagnostic insights, including in cases where interictal epileptic discharges are absent.
What's the money for? The grant will fund dEEGtal’s regulatory work, its first entry into the US market, and the development of distribution partnerships. The company was previously supported by a FIF Grant in 2022.
Who else got funded? S-SENTIADealroom has a profile for this one. Try Dealroom →, a University of Geneva spin-off developing a 3D imaging microchip, received an equal US$91.7K. Juturna Bio, an EPFL spin-off working on epigenetic therapy for brain ageing, and Pixels Métallurgiques, which is building a laser-based metal decoration process, each received a US$45.8K grant.
Why now? The awards continue a steady run of FIF activity through 2026, which has also included US$45.8K grants to three academic spin-off projects and support for Geneva ventures such as Infera NeuroDealroom has a profile for this one. Try Dealroom → and S-SENTIA. The fund’s next application deadline is November 4.
The signal: These are modest, early-stage grants, and they sit below the midpoint for disclosed funding amounts. They point less to private-investor validation than to the FIF’s role in bridging academic research and early commercial development across Geneva’s institutions.
Read more: startupticker.ch
Image credit: Generated with Gemini
